Unum Group 6.250% Junior Subordinated Notes due 2058 (UNMA)

Total Costs & Expenses

$2.96B

Quarterly · Period ending: · USD

UNMA logo

UNMA Total Costs & Expenses

Latest reported$2.96B
UNMA Quarterly Total Costs & Expenses ($447.10M → $2.96B)
High-resolution chart · PNG

UNMA total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Unum Group 6.250% Junior Subordinated Notes due 2058 Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
2,961,500,000
3,052,500,000
3,024,100,000
3,303,000,000
2,928,800,000
2,833,900,000
2,757,000,000
2,315,700,000
2,709,500,000
2,684,800,000
2,695,000,000
2,807,300,000
2,595,100,000
2,571,200,000
2,629,400,000
2,305,300,000
2,547,200,000
2,656,100,000
2,745,000,000
2,521,500,000
2,730,400,000
2,843,900,000
4,083,300,000
2,687,000,000
2,722,300,000
2,715,100,000
2,655,900,000
2,681,400,000
2,652,100,000
2,634,300,000
2,571,100,000
3,295,100,000
2,535,500,000
2,558,500,000
2,493,900,000
2,452,300,000
2,460,400,000
2,476,200,000
2,425,300,000
2,431,200,000
2,421,100,000
2,421,200,000
2,405,800,000
2,358,900,000
2,383,900,000
2,344,400,000
3,093,600,000
2,297,300,000
2,307,000,000
2,284,600,000
2,280,400,000
2,256,800,000
2,290,400,000
2,321,000,000
2,335,500,000
2,307,600,000
2,321,500,000
2,301,300,000
3,309,100,000
2,256,900,000
2,230,000,000
2,235,700,000
2,257,600,000
2,201,400,000
2,202,500,000
2,200,400,000
2,200,700,000
2,182,900,000
2,216,800,000
2,198,300,000
2,271,200,000
2,282,900,000
2,308,300,000
2,295,900,000
2,418,100,000
2,331,200,000
2,432,700,000
2,340,700,000
2,302,300,000
2,714,800,000
2,432,100,000
2,492,500,000
2,470,800,000
2,475,600,000
2,390,900,000
2,390,300,000
2,533,800,000
2,399,500,000
2,397,200,000
3,393,900,000
2,563,400,000
2,408,600,000
2,391,800,000
2,784,300,000
2,278,900,000
255,100,000
258,200,000
252,400,000
2,118,000,000
2,184,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.